Steady State Pharmacokinetics of 80 mg Telmisartan (Micardis), 10 mg Ramipril (Delix) or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers (an Open-label, Randomised, Multiple-dose, Three-way Crossover Study)

Trial Profile

Steady State Pharmacokinetics of 80 mg Telmisartan (Micardis), 10 mg Ramipril (Delix) or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers (an Open-label, Randomised, Multiple-dose, Three-way Crossover Study)

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2014

At a glance

  • Drugs Ramipril (Primary) ; Telmisartan (Primary)
  • Indications Cardiovascular disorders; Hypertension
  • Focus Pharmacokinetics
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 25 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top